Cart
sales@molnova.com
PF-17
CAS No. 2697145-21-2
PF-17( —— )
Catalog No. M36412 CAS No. 2697145-21-2
PF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 301 | Get Quote |
|
| 5MG | 542 | Get Quote |
|
| 10MG | 732 | Get Quote |
|
| 25MG | 1095 | Get Quote |
|
| 50MG | 1454 | Get Quote |
|
| 100MG | 1944 | Get Quote |
|
| 500MG | 3897 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-17
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
-
DescriptionPF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2697145-21-2
-
Formula Weight448.54
-
Molecular FormulaC21H28N4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=CC(N2CCC(NC(OC(C)(C)C)=O)CC2)=NC=N1)C3=CC=C(S(C)(=O)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Hydroxybenzophenon...
Used in organic synthesis, is an intermediates of infertility drugs Clomifene .
-
Carcinoembryonic Ant...
Carcinoembryonic antigen (CEA) is a protein that is present in certain tissues of a developing baby (fetus)
-
BAY-43-9695
BAY-43-9695 is a non-nucleoside compound with anti-human cytomegalovirus (HCMV) activity. It is the major metabolite of BAY-38-4766.
